Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 55 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 7345030

    Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals

    Third Military Medical University, Chinese People's Liberation Army, P.R. of China · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted

  2. US 7338652

    Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents

    Provectus Pharmatech, Inc. · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted

  3. US 7335646

    Compositions and methods for regulated protein expression in gut

    ENGENE, INC. · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted

  4. US 7332469

    Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions

    The Board of Regents of the University of Texas System · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted

  5. US 7332159

    Method and composition for inhibiting reperfusion injury in the brain

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted

  6. US 7329502

    ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted

  7. US 7320965

    Compositions and methods for inhibiting expression of Huntingtin gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 22, 2008 · Expires Jan 17, 2028

    granted

  8. US 7314731

    Method for selecting therapeutic agents for cancer

    Precision Therapeutics, Inc. · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted

  9. US 7314624

    Nanoemulsion vaccines

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted

  10. US 7309693

    Preventives and remedies for pulmonary hypertension

    Takeda Chemical Industries Ltd. · Granted Dec 18, 2007 · Expires Dec 13, 2027

    granted

  11. US 7300774

    Multimeric fusion proteins of the TNF superfamily ligands

    The Regents of the University of California · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted

  12. US 7285542

    Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  13. US 7279306

    Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof

    The Regents of the University of Colorado · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  14. US 7279163

    Water-in-oil emulsion vaccines

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  15. WO 2007104583

    COMPRIMÉ SÉCABLE AVEC PRÉCISION

    BERLIN CHEMIE AG [DE] · Granted Sep 20, 2007 · Expires Sep 15, 2027

    granted

  16. US 7267978

    Chimeric transcriptional regulatory element compositions and methods for increasing prostate-targeted gene expression

    The Regents of the University of California · Granted Sep 11, 2007 · Expires Sep 6, 2027

    granted

  17. US 7265208

    Fusion molecules and treatment of IgE-mediated allergic diseases

    The Regents of the University of California · Granted Sep 4, 2007 · Expires Aug 30, 2027

    granted

  18. US 7244617

    Diminishing viral gene expression by promoter replacement

    The Board of Regents of the University of Texas System · Granted Jul 17, 2007 · Expires Jul 12, 2027

    granted

  19. US 7241860

    Transcription factor polypeptide that regulates Chondromodulin-I expression

    Takeda Pharmaceutical Company Limited · Granted Jul 10, 2007 · Expires Jul 5, 2027

    granted

  20. US 7238366

    Submicron liposome suspensions obtained from preliposome lyophilizates

    The Board of Regents of the University of Texas System · Granted Jul 3, 2007 · Expires Jun 28, 2027

    granted

  21. US 7232671

    Pertussis toxin gene: cloning and expression of protective antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2007 · Expires Jun 14, 2027

    granted

  22. US 7227010

    Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy

    The United States of America as represented by the Secretary of the Army · Granted Jun 5, 2007 · Expires May 31, 2027

    granted

  23. US 7220719

    Modulation of endogenous gene expression in cells

    Sangamo Biosciences, Inc. · Granted May 22, 2007 · Expires May 17, 2027

    granted

  24. CA 2628716

    PROCESSUS DE REGULATION DE LA DIMENSION DE PARTICULE

    ALPHAPHARM PTY LTD [AU] · Granted May 18, 2007 · Expires May 13, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.